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ABSTRACT
Translation of most eukaryotic mRNAs involves the
synergistic action between the 5’ cap structure and
the 3’ poly(A) tail at the initiation step. The poly(A)
tail has also been shown to stimulate translation of
picornavirus internal ribosome entry sites (IRES)-
directed translation. These effects have been attrib-
uted principally to interactions between eIF4G
and poly(A)-binding protein (PABP) but also to the
participation of PABP in other steps during transla-
tion initiation. As the rabbit reticulocyte lysate (RRL)
does not recapitulate this cap/poly(A) synergy,
several systems based on cellular cell-free extracts
have been developed to study the effects of poly(A)
tail in vitro but they generally exhibit low transla-
tional efficiency. Here, we describe that the non-
nuclease-treated RRL (untreated RRL) is able to
recapitulate the effects of poly(A) tail on translation
in vitro. In this system, translation of a capped/
polyadenylated RNA was specifically inhibited
by either Paip2 or poly(rA), whereas translation
directed by HCV IRES remained unaffected.
Moreover, cleavage of eIF4G by FMDV L protease
strongly stimulated translation directed by the
EMCV IRES, thus recapitulating the competitive
advantage that the proteolytic processing of eIF4G
confers to IRES-driven RNAs.
INTRODUCTION
Translation initiation is a highly ordered process that
involves the concerted action of several polypeptides
called eukaryotic initiation factors (eIFs) and other
accessory proteins which facilitate the recruitment of the
ribosome onto the mRNA molecule (1). In eukaryotes,
virtually all nuclear-encoded mRNAs possess an
m
7GpppN (where N is any nucleotide) cap structure at
their 50 terminus and a poly(A) tail (50–300nt) at the 30
end. These structures have been shown to act synergisti-
cally to promote translation initiation in yeast, mammals
and plants in vivo (2).
The 50 cap moiety is recognized and bound by eIF4F
which is composed by the cap-binding protein eIF4E, the
ATP-dependent RNA helicase eIF4A and the scaﬀold
protein eIF4G (3). In mammals, the interaction between
the 40S ribosomal subunit-associated initiation factor
eIF3 and eIF4G bridges the ribosome to the 50 end of the
mRNA. A growing number of viral and cellular RNAs
use an alternative cap-independent mechanism that allows
the recruitment of the ribosome internally by interaction
of RNA structures located in the 50-UTR and called
internal ribosome entry sites (IRES) (4,5). The mechanism
of IRES-dependent translation does not require the cap-
binding protein eIF4E and allows eﬃcient protein synth-
esis under conditions where cap-dependent translation is
either repressed or shut oﬀ (6–8).
Genetic and biochemical studies have shown that
eIF4G interacts with the poly(A)-binding protein
(PABP) in yeast, plants and mammals promoting a
pseudocircularization of the mRNA (9–11). The circular-
ization of a capped and polyadenylated transcript could
even be visualized by high-resolution microscopy using
puriﬁed yeast eIF4E, eIF4G and PABP (12). PABP is a
highly conserved protein among species which covers the
length of the poly(A) tail on the mRNA. It contains four
RNA-recognition motifs (RRMs 1–4) and a C-terminal
domain (CTD) that is responsible for many protein–
protein interactions including translation factors eIF4G,
eIF4B and eRF3 (13). The interaction between eIF4G and
PABP stimulates translation initiation and several possi-
ble mechanisms have been proposed to explain this eﬀect,
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circularization of the mRNA, (ii) an increase in the
association of 60S ribosomal subunits and (iii) a higher
aﬃnity of the eIF4F holoenzyme for the cap structure.
The recent characterization of the PABP-interacting
proteins, Paip1 and Paip2 (which stimulates and represses
poly(A)-dependent translation, respectively) conﬁrm that
protein synthesis can be regulated by 50 to 30 interactions
of the mRNA (14,15).
Translation in the conventional nuclease-treated rabbit
reticulocyte lysate (RRL) and other nuclease-treated cell-
free in vitro systems fail to recreate the selective advantage
conferred by addition of the poly(A) tail to the mRNA
(16–18). As a consequence, several in vitro systems that
recapitulate a high level of competitiveness have been
developed to study the cap/poly(A) synergy in vitro
(11,16,19–21). All these cell-free systems were very
successful in mimicking the competitive cellular environ-
ment and have been instrumental to improve our knowl-
edge about the role of the cap/poly(A) tail interaction in
initiation on both cap- and IRES-dependent translation
(22–24). However, these in vitro systems are somehow very
tedious to make and they exhibit relatively poor transla-
tional eﬃciency. Recently, an in vitro system based on a
nuclease-treated RRL partially depleted from its ribo-
somes by ultracentrifugation has been engineered (25).
Although the latter recapitulates well the cap/poly(A)
synergy and is relatively simple to make, it exhibited very
poor translational eﬃciencies compared to the parental
reticulocyte lysate probably due to the depletion of some
rate-limiting ribosome-associated factors.
Here, we show that the commercially available
untreated RRL that contains endogenous mRNAs
(globin and lipoxygenase principally) is able to recreate
very faithfully the cap/poly(A) tail synergy in vitro.
Interestingly, this system also recapitulates the selective
advantage displayed by the EMCV IRES under condi-
tions of cap-dependent translation inhibition ex vivo that
is not appreciated in the nuclease-treated RRL.
In summary, the results presented here place the untreated
RRL as a very good and reliable in vitro system to recreate
a ‘near to physiological translational environment’ that
can be easily used as a tool for functional studies in
translation.
MATERIALS AND METHODS
DNA constructions
The pGEM-Renilla vector was recently described and
used as template to generate polyadenylated and non-
polyadenylated transcripts by digestion with EcoRI or
SmaI, respectively (26). The 80nt region containing the T7
promoter was deleted by PvuII/BamHI digestion and the
resulting vector was used to insert the diﬀerent 50-UTRs.
The human b-globin 50-UTR with the authentic initiation
codon was obtained by hybridizing two synthetic oligo-
deoxyribonucleotides (Eurogentec) and cloned into the
double-digested vector (EcoRV and BamHI restriction
sites and T7 promoter were added with the oligos)
generating the pGlobin-renilla vector. The EMCV and
HCV IRES were obtained by PCR using the pXL EMCV
(27) and the pDC HCV vectors (28), respectively as
templates. Both PCR products were EcoRV/BamHI-
digested and cloned in the double-digested vector (T7
promoter and restriction sites were added by PCR)
generating pEMCV-renilla and pHCV-renilla vectors,
respectively. In the case of pHCV-renilla, as the HCV
IRES contains two SmaI sites, the SmaI site at the end
of the renilla coding region was changed to an XhoI
site by site-directed mutagenesis (QuickChange XL,
Stratagene).
In vitro transcription
The four possible combinations, capped/polyadenylated
(+/+), capped/non-polyadenylated (+/ ), uncapped/
polyadenylated ( /+) and uncapped/non-polyadenylated
( / ) were obtained by in vitro transcription using the
linear template of pRenilla vector that was linearized
either at the SmaI (non-polyadenylated RNAs) or at the
EcoRI site (polyadenylated RNAs) (Figure 1A). It should
be noted that non-polyadenylated RNA do not contain
any 30-UTR after the luciferase coding region. Uncapped
RNAs were obtained by using 2mg of linear DNA
template, 20U of T7 RNA polymerase (Promega Co.,
Madison, WI, USA), 40U of RNAsin (Promega Co,
Madison, WI, USA), 10mM of each ribonucleotide
triphosphate, 30mM DTT in transcription buﬀer
[40mM Tris–HCl (pH 7.9), 6mM MgCl2, 2mM spermi-
dine and 10mM NaCl]. For capped RNAs, the rGTP
concentration was reduced to 0.48mM and the m
7GpppG
cap analogue (Invitrogen, Co) was added to a ﬁnal
concentration of 1.92mM as previously described (29).
The transcription reaction was carried out at 378C for
1.5h and the RNAs were precipitated with LiCl at 2.5M
ﬁnal concentration. The integrity of the RNAs was
checked by electrophoresis on non-denaturating agarose
gels and their concentration was quantiﬁed by spectro-
photometry at 260nm using Nanodrop (NanoDrop
Technologies, Wilmington, Delaware, USA).
Capped and polyadenylated ‘natural’ globin mRNAs
were purchased from Gibco (Gibco BRL).
Preparation of theuntreated RRL andin vitro
translation reactions
The untreated RRL was supplemented as previously
described [(30,31), Morley, S., personal communication].
Brieﬂy, 1ml of untreated RRL (Promega Co., Madison,
WI, USA) was supplemented with 25mM haemin (Fluka),
25mg/ml creatine phosphokinase (Sigma-Aldrich Co.),
5mg/ml creatine phosphate (Fluka), 50mg/ml of bovine
liver tRNAs (Sigma-Aldrich Co.) and 3mM of D-glucose
(Sigma-Aldrich Co.). In vitro transcribed RNAs were
translated in 10ml of the supplemented untreated RRL or
the Flexi Rabbit Reticulocyte System 50% (v/v) each
(Promega Co., Madison, WI, USA) in the presence of KCl
(75mM), MgCl2 (0.5mM), 20mM of amino acids mix
minus methionine and 0.6mCi of [
35S]-methionine (GE
Healthcare Life Sciences) for 30min at 308C. Reactions
were stopped with 2 SDS-loading buﬀer and the
products were resolved by 15% SDS–PAGE. Gels were
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ﬁlms (Eastman Kodak Co.). Densitometric analyses were
performed by Phospho Imaging with a Fuji FLA-5100
imaging system (Fujiﬁlm Life Sciences) using the
ImageReader FLA-5000 software (Fujiﬁlm Life Sciences).
Renilla luciferase activity
Renilla activity from translation reactions carried out
without [
35S]-methionine was measured in a Veritas
TM
Luminometer (Turner Biosystems) using the Renilla
Luciferase Assay System (Promega, Madison Co).
Recombinant GST-Paip2
BL21(DE3)CodonPlus-RP bacteria (Stratagene) were
transformed with pGEX–Paip2 (a kind gift from Dr
Dalla Venezia). Bacterial culture was grown at 308Ct oa
density of A600=0.4, then induced with IPTG at a ﬁnal
concentration of 1mM and shaken for additional 3h at
208C. The cells were lysed by freeze/thaw cycles, lysozyme
addition and sonication in buﬀer A (50mM MOPS–KOH
pH 7.2, 50mM NaCl, 10mM EDTA, 2mM DTT and
10% glycerol). The GST-Paip2 proteins were puriﬁed
from the soluble fraction using Glutathione Sepharose 4B
(GE Healthcare Life Sciences). Proteins were washed with
buﬀer B (50mM MOPS–KOH pH 7.2, 100mM NaCl,
10mM EDTA, 2mM DTT, 10% glycerol and 1% Triton-
X100) and eluted with buﬀer A+5mM reduced glu-
tathione (Sigma-Aldrich Co). The fractions were analysed
by Coomassie blue staining. The appropriate fraction was
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Figure 1. (A) Schematic diagram, not to scale, of the constructs used in this study. The cap structure in the RNAs is indicated by a black circle, the
100nt length poly(A) tail is indicated by A(100). (B) Capped/polyadenylated (+/+), capped/non-polyadenylated (+/ ), uncapped/polyadenylated
( /+) or uncapped/non-polyadenylated ( / ) Globin-renilla RNAs were translated at 0.05, 0.1, 0.15 or 0.3mg/ml in the untreated RRL (left panel)
or the nuclease-treated lysate (right panel) as described in Materials and Methods section. Translational products were analysed by 15% SDS–PAGE
and autoradiography. Synthesis of endogenous globin and lipoxygenase together with exogenous renilla products are indicated by arrows on the
ﬁgure. Densitometric quantiﬁcation of renilla synthesis at 0.1mg/ml from Globin-renilla RNA translation in the untreated and nuclease-treated
lysates has been plotted at the bottom of each panel. (C) Capped/polyadenylated (+/+), capped/non-polyadenylated (+/ ), uncapped/
polyadenylated ( /+) or uncapped/non-polyadenylated ( / ) Globin-renilla RNAs were translated at 0.05, 0.1, 0.15 or 0.3mg/ml in the untreated
RRL (left panel) or the nuclease-treated lysate (right panel) as described in Materials and Methods section. Renilla luciferase activity was then
determined and normalized as described in Materials and Methods section. The results presented are representative of three independent experiments
are expressed as means SD.
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100mM KCl, 1mM EDTA, 1mM EGTA, 1mM DTT
and 10% glycerol). The recombinant GST-Paip2 proteins
were analysed for size and integrity by SDS gel electro-
phoresis, followed by staining with Coomassie blue.
Protein concentration was determined with the Biorad
Protein Assay (Bio-Rad Laboratories, Inc.).
GST-Paip2and poly(rA) competition
Translation mixtures were pre-incubated either with
diﬀerent concentrations of recombinant GST-Paip2 or
free poly(rA) (GE Healthcare Life Sciences) for 5min at
308C prior to addition of [
35S]-methionine and RNAs.
FMDV Lprotease
pMM-1 vector that codes for FMDV L protease under the
T7 promoter (32) was linearized with XbaI and tran-
scribed as indicated for uncapped RNAs. The Flexi RRL
system 50% (v/v) (Promega Co, Madison, WI, USA) was
programmed with 2mg of MM-1 RNA and treated as
previously described (33).
RESULTS
The untreated RRL as amodelsystem forcap/poly(A)
synergy studies in vitro
The untreated RRL from a commercial origin (Promega)
was supplemented with haemin, creatine phosphokinase,
creatine phosphate and tRNAs as it was described in the
original publication of Pelham and Jackson (31). For all
experiments described in this article, we have used RNA
constructs that contain the renilla luciferase gene
(pRenilla vector) driven by either the human b-globin
50-UTR, the EMCV IRES or the HCV IRES as stated
(Figure 1A). The untreated RRL contains two endoge-
nous mRNAs, lipoxygenase and globin, which are actively
translated in this system to produce proteins that run at 68
and 15kDa, respectively (Figure 1B, left panel).
Translation of the Globin-renilla RNA in the untreated
lysate system revealed that the presence of both the cap
and the poly(A) tail on the RNA (+/+ on the ﬁgure)
conferred a real advantage for translation (Figure 1B).
Addition of the cap and the poly(A) tail together strongly
stimulated translation of Globin-renilla RNA (more than
4-fold) at 10ng of RNA (Figure 1B, left panel) indicating
that the untreated RRL was able to recapitulate the
synergistic eﬀect of the cap structure and the poly(A) tail
in vitro. At the same RNA concentrations, the eﬀects of
the cap and the poly(A) tail on Globin-renilla RNA
translation resulted in a modest increase (<20%) in the
nuclease-treated reticulocyte lysate (Figure 1B, right
panel) as it was previously described (17). Moreover, the
synergistic eﬀects observed in the untreated RRL were
RNA concentration-sensitive since at high RNA concen-
tration (over 30ng of RNA) no synergy was observed
(data not shown). Interestingly, translation of the ( /+)
and ( / ) Globin-renilla RNA, was very weak demon-
strating the importance of the cap and poly(A) structures
for eﬃcient translation in competitive conditions.
Quantiﬁcation of the luciferase activity from three
independent experiments has been carried out and the
results are presented as graphs (Figure 1C). It should be
noted that the variations in translational eﬃciencies did
not reﬂect any signiﬁcant diﬀerences in RNA stability in
the treated and untreated lysates (data not shown).
The next step was to investigate the role of the cap and
the poly(A) tail in kinetics studies. For this, a low
concentration (10ng) of Globin-renilla RNAs was trans-
lated in both reticulocyte lysate systems and protein
production was analysed at 0, 15, 30 and 60min by
analysis of the renilla luciferase activity (Figure 2A). It is
interesting to note that the kinetics of translation of the
capped and polyadenylated transcript in the competitive
system is much higher than that of the other RNAs
(compare +/+ with all others). It is noteworthy that such
a diﬀerence between the (+/+) and all other transcripts
can be observed right from the early time points
(Figure 2A, compare left and right panel).
Another important matter was to study the eﬀects of
salt concentration changes in both nuclease-treated and
untreated systems as it had been described to be an
important parameter for translational accuracy and
eﬃciency in vitro (31,34). Whereas preferentially similar
values for the optimal KCl concentration were obtained
for (+/+) and (+/ ) RNAs in both systems (data not
shown), a diﬀerent proﬁle was observed when changes in
the MgCl2 concentration were imposed. At high Mg
2+
concentration, an inhibitory eﬀect was observed for all
RNAs tested in the nuclease-treated lysate system
(Figure 2B and C). However, the situation is completely
diﬀerent in the competitive system with a net increase in
translation for the (+/+) RNA construct at elevated level
of exogenously added Mg
2+. Once again, the cap and
poly(A) addition have a synergistic eﬀect at all Mg
2+
tested (Figure 2B and C for the quantiﬁcation of the
luciferase activity). Taken together, these results show
that the untreated RRL system recapitulates faithfully the
cap/poly(A) synergy together with a stimulatory response
to kinetics and salt concentration changes, thus mimicking
physiological conditions encountered within cells.
Paip2 andfree poly(rA)specifically inhibit translation ofa
capped/polyadenylated RNA inthe untreated RRL system
It has recently been shown that the PABP-interacting
protein 2 (Paip2) was able to down regulate poly(A)-
dependent translation by a two-step mechanism: it initially
disrupts the PABP–poly(A) tail interactions (15) and it
directly competes with eIF4G for binding to PABP (35).
Therefore, the eﬀect of recombinant GST-Paip2 addition
has been studied on the translation of Globin-renilla (+/
+) RNA in the untreated lysate system (Figure 3A).
The data show that translation of exogenous capped/
polyadenylated was speciﬁcally inhibited by addition of
recombinant GST-Paip2 in a dose-dependent manner
(reaching  50% of inhibition at the highest concentration
tested). These eﬀects were not due to the presence of the
GST fragment in the fusion protein since the GST alone
did not inﬂuence translation of this RNA. As expected, no
eﬀect could be observed on translation driven by the HCV
e121 Nucleic Acids Research, 2007, Vol. 35, No. 18 PAGE4 OF 9IRES, which has the ability to initiate protein synthesis
independently from eIF4G, PABP and the poly(A) tail
(compare globin and HCV in Figure 3A).
As additional evidence, we have also added free
poly(rA) in trans to the untreated reticulocyte system. It
has been shown that a free poly(rA) oligoribonucleotide
has the ability to speciﬁcally inhibit cap/poly(A) tail-
dependent translation by competing for PABP binding
(17,36,37). Therefore, translation of Globin-renilla (+/+)
RNA was studied under these experimental conditions
(Figure 3B). Addition of increasing concentrations of the
poly(A) polymer resulted in the inhibition of translation of
Globin-renilla (+/+) RNA albeit to a lesser extent than
that obtained with Paip2. Actually, addition of free
poly(rA) inhibited as much as 40% of translation
compared to the control situation but we failed to observe
a clear dose-dependent eﬀect. This result is somehow
similar to that obtained by Munroe and Jacobson ( 50%
of inhibition) (17). A possible explanation for this
relatively low eﬀect on cap/poly(A) translation could
come from the fact that the poly(rA) competitor only
disrupts the interactions between the PABP and the
poly(A) tail without aﬀecting the PABP–eIF4G interac-
tion (35). However, this eﬀect was clearly dependent on
the presence of the poly(A) tail since no inhibition of HCV
IRES-dependent translation was observed in the presence
of poly(rA) (compare globin and HCV in Figure 3B). The
degree of inhibition obtained with both GST-Paip2 and
poly(rA) in the untreated RRL are in complete agreement
with ex vivo data obtained in HeLa cells showing that the
knockout of PABP by RNA interference has only a little
eﬀect (no more than a 20% of inhibition) on translation of
an exogenous RNA (38). These results show that
translation of exogenous Globin-renilla (+/+) RNA in
the untreated RRL system is operated by a cap- and
poly(A)-dependent mechanism that can be selectively
inhibited by blocking the interactions between PABP
and its partners.
The untreated RRL as asystem to study
IRES-dependent translation
Several studies have now shown that the poly(A) tail can
stimulate picornavirus IRES-mediated translation to a
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Figure 2. (A) Diﬀerent combinations of Globin-renilla RNAs (+/+), (+/ ), ( /+) or ( / ) were translated at 0.1mg/ml for 0, 15, 30 or 60min in
the nuclease-treated RRL (left panel) or untreated RRL (right panel) as indicated on the ﬁgure. Renilla luciferase activity was then determined and
normalized as described in Materials and Methods section.(B) Globin-renilla RNAs (+/+), (+/ ), ( /+) or ( / ) at 0.1mg/ml were translated in
both nuclease-treated RRL (left panel) or untreated RRL (right panel) in the presence of 0, 0.25, 0.5 or 1mM added MgCl2. The resulting translation
products were resolved by 15% SDS–PAGE and autoradiography and the position of the protein products are indicated by arrows on the ﬁgure.
(C) Globin-renilla RNAs (+/+), (+/ ), ( /+) or ( / ) at 0.1mg/ml were translated in both nuclease-treated RRL (left panel) or untreated RRL
(right panel) in the presence of 0, 0.25, 0.5 or 1mM added MgCl2. Renilla luciferase activity was then determined and normalized as described in
Materials and Methods section. The results presented are representative of three independent experiments are expressed as means SD.
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in vitro system from Krebs-2 cell extracts, Svitkin and
colleagues (21) have shown that the presence of compet-
itors RNAs was required to observe an important
stimulation of translation driven by the EMCV IRES
following the cleavage of eIF4G by picornaviral proteases.
Such a system recapitulates faithfully the situation
encountered during picornaviral infection and can be
explained by the fact that the low availability of eIF4E
bound to eIF4F was critical to confer a strong advantage
to IRES-mediated translation which does not require the
cap-binding protein.
In order to analyse the ability of the untreated RRL to
recreate these eﬀects, polyadenylated and non-polyadeny-
lated versions of an EMCV-renilla RNA (designed EMCV
 /+ and EMCV  / , respectively) were translated in
parallel in the nuclease-treated (Figure 4A, left panel) and
the untreated (Figure 4A, right panel) RRLs in the
presence of increasing concentrations of an in vitro-
synthesized FMDV L protease. As seen in the ﬁgure,
translation of both EMCV RNAs was moderately
stimulated by the cleavage of eIF4G in the nuclease-
treated RRL. In sharp contrast with these data, a large
increase of EMCV IRES-mediated translation upon
addition of the L protease was observed in the untreated
competitive lysate (over 5-fold enhancement, Figure 4A,
right panel). Interestingly, at the same time, translation of
endogenous globin mRNA was inhibited (see bottom of
the gel) thus providing an internal control to monitor
the extent of cap-dependent translation inhibition.
In the context of our experimental conditions, treatment
with 0.6ml of L protease resulted in the cleavage of
virtually all endogenous eIF4GI contained in the lysate as
visualized by western blotting analysis (Figure 4B).
These results are in complete agreement with those
obtained by Svitkin and colleagues and indicate that
inhibition of cap-dependent translation by eIF4G cleavage
(L protease) in the untreated RRL strongly stimulates
IRES-mediated translation thus recreating the competitive
advantage observed for IRES-dependent translation
in vivo. It shouldbe notedthat similar results were obtained
by using m
7GpppG cap analogue (data not shown).
Addition ofsaturating concentration ofglobin mRNA
in thenuclease-treated reticulocyte lysate
Data obtained so far show that the untreated reticulocyte
lysate recapitulates cap/poly(A) synergy and the selective
advantage of IRES-driven translation under conditions
where cap-dependent translation was inhibited. The fact
that cap/poly(A) synergy cannot be observed in the
nuclease-treated RRL suggests that the presence of
endogenous globin mRNAs may play a key role in the
regulation of translation probably by competing for the
translational apparatus. However, another possibility
could be that the treatment of the reticulocyte lysate
with micrococcal nuclease may also alter some compo-
nents of the translational apparatus rendering them
limiting for translation of exogenously added mRNAs.
Thus, to address this question we have added saturating
amounts of exogenous globin mRNAs (Gibco) to a
nuclease-treated reticulocyte lysate programmed with
luciferase mRNAs (Figure 5, right panel). An incubation
in the nuclease-treated lysate without inclusion of
exogenous globin mRNAs was carried out in parallel
(Figure 5, left panel). From these graphs it can be
observed that there is a diﬀerence in the translational
pattern as the uncapped transcripts were not expressed in
the system supplemented with exogenous globin (right
graph). However, it is also clear that cap/poly(A) synergy
was not restored by the addition of competitor RNAs
although both the cap and the poly(A) provided a selective
advantage. Taken together these results show that the cap/
poly(A) synergy is not totally attributable to competition
for the translational apparatus in this system.
DISCUSSION
As early as in the 1980s the ﬁrst reports from the
Jacobson’s group showed that addition of free poly(A)
to mammalian translation extracts was inhibitory for
capped and polyadenylated mRNAs but stimulatory
for poly(A)-deﬁcient mRNAs suggesting a possible role
for the poly(A) tail in translational control (17,37). Later,
the characterization of PABPs in yeast and mammals
introduced a possible role for the poly(A) tail in
translation (39–41). In the early 1990s, Sachs and Davis
(42) showed that mutations in the yeast PAB1 gene
(encoding Pabp1) resulted in an inhibition of translation
and cell growth indicating that this gene was essential
in yeast.
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Figure 3. (A) Capped and polyadenylated Globin-renilla RNAs (+/+)
and uncapped and non-polyadenylated HCV-renilla RNAs ( / ) were
translated in the untreated reticulocyte lysate that had been pre-
incubated with 50, 100 or 250ng of GST-Paip2 recombinant protein or
(B) 10, 20 or 30ng of free poly(rA). Protein production was determined
by densitometric quantiﬁcation of the renilla protein product and is
expressed as percent of the control (no inhibitor added, set to 100%).
Data were obtained from densitometric analyses of at least three
independent experiments and are expressed as means SD.
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and coworkers who showed that the cap and poly(A) tail
conferred an important translational competitive advan-
tage to mRNAs delivered directly to the cytoplasm of
yeast, plants and mammalian cells (2). They further show
that the stimulatory eﬀect added by both structures at the
mRNA 50 and 30 termini were greater than additives and
they introduced the term ‘synergy’ to the ﬁeld.
The design of the ﬁrst yeast-based cell-free translation
system that could recapitulate the cap/poly(A) synergistic
eﬀect was very instrumental for functional in vitro
translational studies (16). A condition to obtain synergis-
tic stimulation of translation by the cap and poly(A) tail
seems to require the presence of competitors RNAs since
synergy was observed in non-nuclease-treated extracts or
nuclease-treated extracts supplemented with an excess of
exogenous RNAs (16,18,43).
Several cell-free translation systems have been success-
fully developed since and they all can reproduce
well the ‘physiological cytoplasmic environment’
(16,18,19,21,22,24,43). However, major drawbacks from
these systems come from the fact that they are usually
technically diﬃcult to prepare and that they are engi-
neered ‘in house’ on a relatively small scale thus posing the
problem of reproducibility.
To circumvent these problems, Kean and colleagues
developed an in vitro system based on the conventional
nuclease-treated RRL that was partially depleted from
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Figure 4. (A) Uncapped polyadenylated ( /+) and uncapped non-polyadenylated ( / ) EMCV-renilla RNAs were translated at 0.5mg/ml during
30min at 308C in both the nuclease-treated (left panel) and untreated RRLs (right panel) that were pre-incubated with 0, 0.2, 0.4 or 0.6mlo fa n
in vitro-synthesized FMDV L protease (see Materials and Methods section). Translation products were resolved by 15% SDS-PAGE followed
by autoradiography. Densitometric analysis of the renilla protein product was performed and expressed as percentage of the control (100%,
no L protease added) at the bottom of each panel. (B) At the end of the in vitro translation incubation, samples (1ml) from the experiment described
above were run on a 10% SDS–PAGE and the proteins transferred to PVDF membrane and incubated with antibodies speciﬁc to the C-terminal
part of eIF4GI.
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Figure 5. Diﬀerent combinations of Globin-renilla RNAs (+/+), (+/ ), ( /+) or ( / ) were translated at 0.1mg/ml for 30min at 308C in the
nuclease-treated RRL (left graph) or nuclease-treated RRL supplemented with 0.15mg/ml of globin mRNAs (Gibco) (right graph) as indicated on
the ﬁgure. Translation products were quantiﬁed by analysis of luciferase activity.
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Although, this system was able to recreate the eﬀects of
polyadenylation, its translational eﬃciency remained
extremely low compared to the parental lysate and they
require from 1 to 10 days to obtain a detectable signal on
the autoradiography (23,25).
Here we describe the translational properties of the
untreated reticulocyte lysate which appear to be a very
good model system to faithfully recapitulate cap/poly(A)
synergy. We show that exogenously added RNAs can be
translated in this system and protein production can be
measured by incorporation of [
35S] methionine as
described previously (31). This results in the labelling of
the lipoxygenase at 68kDa and globin at 15kDa together
with the protein product from the exogenously added
RNA such as renilla luciferase (Figure 1B). The diﬀerence
in size allows a clear distinction between these three
proteins which facilitates the interpretation of the data.
Moreover, endogenous globin production can be used as
an internal control for cap-dependent translation when
various inhibitors are added (Figure 4). The reason why
the nuclease-treated RRL is unable to restitute cap/
poly(A) synergy remains unknown but the experiment
presented in Figure 5 suggests that it is not entirely due to
the lack of competition with endogenous RNAs and may
be also attributable to some eﬀect of the micrococcal
treatment itself.
In summary, the untreated RRL system exhibits
very interesting properties to study in vitro translation
as: (i) it recapitulates faithfully cap and poly(A) synergy
(Figure 1B), (ii) it responds well to variations of divalent
salt concentration (Figure 2A), (iii) it is sensitive to Paip2
and poly(rA) additions which are known inhibitors of
poly(A)-dependent translation (Figure 3) and (iv) it
mimics the beneﬁcial competitive environment for IRES-
driven translation that is encountered following the
cleavage of eIF4G by viral proteases (Figure 4).
All these properties make the untreated reticulocyte
lysate a convenient alternative in vitro method for studies
on translational control.
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